On October 19th, 2021 PERMIT WP6 hosted a virtual workshop on study designs of clinical trials (CTs) for personalised medicine (PM) with 22 stakeholders from the PM research ecosystem. The workshop aimed to develop a single definition of CT for PM, valid for all participants and to identify the specific characteristics of a CT for PM on which future recommendations should focus. In addition, the workshop sought to identify the study designs for assessing a PM vs. non-PM strategy and its attributes. Focus groups will be organized with experts to further discuss some challenges raised during the workshop. Insights and comments of all participants will be used to develop a more advanced version of the recommendations.
A new publication about robust & reproducible preclinical research in #PersonalisedMedicine has been published in BMCMedicine. Among the authors are EATRIS staff & institutions members. Congrats to all involved. 👉Find out more hereatris.eu/news/new-publi…w#PERMITprojectect https://t.co/kp46SdWB9G
New #PERMITProject publication: Recommendations for robust & reproducible preclinical research in personalised medicine. 15 recommendations are presented aiming to improve the robustness of preclinical methods in translational research for PM. permit-eu.org/publications https://t.co/zAS8pYOlOm